- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05785494
Web-based Support for Family Caregivers of Patients With Advanced Cancer
August 5, 2025 updated by: Anette Alvariza, Ersta Sköndal University College
Web-based Support to Promote Preparedness for Caregiving Among Family Caregivers of Patients With Advanced Cancer
For family caregivers of patients with advanced cancer, preparedness for caregiving is crucial for maintaining health and quality of life both during care and after the death of the patient.
This project contributes to earlier research funded by the Swedish Cancer Society, about an intervention that was delivered by a multi-professional team and proved to be successful in promoting preparedness.
However, such interventions are often costly and logistically challenging.
In addition, the Covid-19 pandemic has further significantly raised the need for digital alternatives in healthcare.
As a possible solution, an evidence-based intervention, narstaende.se, has been developed consisting of recorded videos of conversations between clinicians and family caregivers (actors), linked to informational texts and a moderated chat forum.
The intervention was pilot tested during 2020 and 2021, exploring feasibility, content and family caregivers' experiences.
As preliminary results are promising, the intervention is taken one step further and tested as a web-based intervention in a larger scale.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
204
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Stockholm, Sweden, 100 61
- Marie Cederschiöld University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being a family caregiver, over 18 years of age, to a person with life-threatening illness cared for in specialized home care.
Exclusion Criteria:
- Not being able to communicate in Swedish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Standard care
|
|
|
Experimental: Intervention
Access to web-site
|
Web-site with supportive information, videos and chat forum targeting family caregivers of patients with life-threatening illness.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Preparedness for caregiving
Time Frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
Preparedness for caregiving scale (PCS)
|
At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Quality of Life
Time Frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
The Quality of Life in Life-Threatening Illness Family caregiver version (QOLLTI-F)
|
At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
|
Change in health
Time Frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
RAND- 36
|
At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
|
Change in Anxiety and Depression
Time Frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
The Hospital Anxiety and Depression Scale (HADS)
|
At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
|
Change in pre-loss grief
Time Frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
Prolonged Grief-12
|
At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
|
Change in post-loss grief
Time Frame: At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
Prolonged Grief-13
|
At baseline (before intervention), change from baseline after 4-6 weeks (follow-up 1) and after 8-10 weeks (follow-up 2)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2022
Primary Completion (Actual)
December 31, 2023
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
February 27, 2023
First Submitted That Met QC Criteria
March 14, 2023
First Posted (Actual)
March 27, 2023
Study Record Updates
Last Update Posted (Actual)
August 8, 2025
Last Update Submitted That Met QC Criteria
August 5, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MarieCederschiöldUniversity
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End of Life
-
Universidade do PortoCompleted
-
The Hong Kong Polytechnic UniversityRecruiting
-
Regional Palliative Care NetworkCompleted
-
Centre Hospitalier Universitaire de Saint EtienneRecruiting
-
Hadassah Medical OrganizationClalit Health Services; Israel Center for Medical Simulation (MSR); The Samuel...UnknownEnd of Life ProcessIsrael
-
Umeå UniversityCompleted
-
Istanbul UniversityActive, not recruiting
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Nanyang Technological UniversityHCA Hospice CareUnknown
-
US Department of Veterans AffairsCompleted